INTECH Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History

INTECH Investment Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$708K	Sell	30,300 -10,493	-26%	-$228K	0.01%	1173
2025 Q4	$857K	Buy	40,793 +6,918	+20%	+$121K	0.01%	1215
2025 Q3	$521K	Sell	33,875 -11,878	-26%	-$155K	﹤0.01%	1560
2025 Q2	$428K	Sell	45,753 -9,911	-18%	-$109K	﹤0.01%	1701
2025 Q1	$684K	Buy	55,664 +23,146	+71%	+$326K	0.01%	1440
2024 Q4	$430K	Buy	32,518 +10,236	+46%	+$175K	﹤0.01%	1644
2024 Q3	$429K	Buy	+22,282	New	+$460K	﹤0.01%	1311

Other funds holding SNDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

INTECH Investment Management's SNDX Position: Q1 2026 in Review

INTECH Investment Management reduced its Syndax Pharmaceuticals (SNDX) stake by 26% in Q1 2026, selling an estimated $228K and leaving 30,300 shares worth $708K. The position accounts for 0.01% of the portfolio, ranked #1173.

INTECH Investment Management first reported a position in SNDX in Q3 2024 and has held it in 7 quarters since. The position peaked at $857K in Q4 2025. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

INTECH Investment Management held 30,300 shares of Syndax Pharmaceuticals worth $708K as of Q1 2026.
INTECH Investment Management sold 10,493 Syndax Pharmaceuticals shares in Q1 2026, an estimated $228K.
Syndax Pharmaceuticals made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1173 holding.
INTECH Investment Management first reported a position in Syndax Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
INTECH Investment Management's Syndax Pharmaceuticals position peaked at $857K in Q4 2025.
246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.